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MATERIALS AND METHODS:
Cell culture, adenoviral infections, and antimetabolite treatment.
Rat-16 and A2-4 cell lines were cultured and infected with cyclin E-encoding adenovirus (Gustavo Leone, Ohio State University) as previously described (16) .
Murine embryonic fibroblasts (MEFs) of either Rb +/+ or Rb -/-genotype, between passage 2 and 6, were obtained and cultured as described previously (17) . CV1 cells were cultured as previously described (18) . CV1 cells were infected with p16ink4a-encoding adenovirus (Timothy Kowalik, University of Massachusetts) as previously described (19) .
For flow cytometric analysis, dNTP pool analysis, and PCNA extraction of hours. All compounds were purchased from Sigma.
Array analysis:
Total RNA was isolated from Rat-16 and A2-4 cells using Trizol (Gibco), according to the manufacturer's protocol. RNA was then subjected to microarray analysis using Affymetrix genechips RatU34A, B, and C (Markey et al., submitted).
Immunofluorescence microscopy:
Approximately 10 5 A2-4 cells were grown on coverslips in six-well dishes.
Approximately 10 4
MEFs were grown on coverslips in 24-well dishes. For bromodeoxyuridine (BrdU) incorporation, A2-4 cells or MEFs were pulse-labeled for 1 hour or 2 hours respectively, and stained as previously described (20) . PCNA immunofluorescence was performed on in situ extracted coverslips as previously described (16) . PCNA antibody (PC10) was from Santa Cruz.
Flow cytometry analysis:
Subsequent to Dox removal, adenoviral infection, or antimetabolite treatment, cells were harvested by trypsinization, fixed with ethanol, stained with propidium iodide, and processed for flow cytometry as previously described (21) .
Immunoblotting and kinase assay:
Immunoblotting was performed using standard procedures and the following antibodies from Santa Cruz: cyclin A (C- 19) , cyclin E (M-20 and HE12), CDK2 (M2-G),
RNR-R1 (Y-16), RNR-R2 (I-15), and CDK4 (H-22). DHFR monoclonal antibody was from Transduction Laboratories. Polyclonal TS antibody was a kind gift from Masakazu
Fukushima (Taiho Pharmaceutical) (22) . PSM-RB and endogenous RB were detected using 851 antibody.
For in vitro kinase assays, cells were lysed and CDK2 immune-complexes were recovered and used to phosphorylate histone H1 substrate as previously described (20) .
dNTP pool extraction and analysis:
Asynchronously proliferating Rat-16 or A2-4 cells were cultured as described.
For each analysis, the cells in three 10-cm plates were washed with 5 ml each of cold PBS. Extraction was carried out with 3 ml per plate of ice-cold 60% methanol/1%
toluene. Plates were incubated at -20°C for 2 hours, following which the fluid was recovered and each plate was washed with an additional 1 ml of the methanol/toluene solution. Following this, all suspensions and washes were pooled. The remainder of the extraction was carried out as described by Sargent and Mathews (23) . Analysis of the dNTP pools in each extract was carried out as described by Sherman and Fyfe (24) . 
RESULTS:
Cyclin E fails to overcome RB-mediated cell cycle inhibition:
It is well established that RB regulates S-phase by influencing CDK2 activity, as the ectopic expression of cyclins can promote S-phase entry in the presence of constitutively active alleles of RB (21, 25, 26) . However, the replication is incomplete and cells fail to progress into G2 phase. Here, we sought to uncover the additional, CDK2-independent mechanism through which RB inhibits DNA replication. We utilized an established system in which the expression of a constitutively active allele of RB, PSM-RB, can block DNA replication (21) . To verify these results and determine the action of PSM-RB on the biochemical activities associated with DNA replication, a cell line that inducibly expresses PSM-RB was utilized (16) . In this rat fibroblast cell line (A2-4), PSM-RB expression was induced by removal of doxycycline (Dox) from the medium for 16 hours (Fig. 1A , compare lanes 1 and 2). Expression of PSM-RB led to an accumulation of cells with a 2N DNA content as determined by flow cytometry (Fig. 1C , mock-infected, compare +/-Dox).
To investigate the effect of cyclin E overproduction on this inhibition of cell cycle progression, a recombinant adenovirus encoding human cyclin E was employed. Ectopic expression of cyclin E was confirmed in infected cells by immunoblotting with an antibody specific for human cyclin E (Fig. 1A, lanes 3 and 4) . To confirm that ectopic cyclin E expression restored CDK2 activity, we performed in vitro kinase assays (Fig.   1B ). As previously observed, the expression of PSM-RB inhibited CDK2 activity (Fig.   1B , mock-infected, compare lanes 2 and 3). In contrast, overproduction of cyclin E in the presence of PSM-RB restored the in vitro activity of CDK2 complexes (Fig. 1B, cyclin E-infected, compare lanes 5 and 6). While the adenoviral infection had no effect on the expression of PSM-RB (Fig. 1A , compare lanes 2 and 4), ectopic cyclin E expression partially overcame the PSM-RB-mediated arrest, as cells accumulated with greater than 2N DNA content (Fig. 1C , compare mock-and cyclin E-infected, -Dox).
However, the cells co-expressing cyclin E and PSM-RB remained inhibited for DNA replication, failing to attain 4N DNA content. This was not merely a consequence of cyclin E overproduction, as cells expressing cyclin E in the presence of doxycycline exhibited normal cell cycle distribution (Fig. 1C , compare mock-and cyclin E-infected, +Dox). Consistent with inefficient S-phase progression, ectopic cyclin E expression in the presence of PSM-RB resulted in a punctate BrdU labeling pattern (Fig. 1D , compare mock-versus cyclin E-infected BrdU immunofluorescence) (21) .
Expression of active RB specifically disrupts the activity of PCNA, the sliding clamp protein required for processive DNA synthesis (15, 16) . To determine whether the incomplete DNA replication observed upon ectopic cyclin E expression was due to a failure to restore PCNA activity, in situ extraction of asynchronously proliferating cells in the presence or absence of Dox was performed (Fig. 1E ). This procedure removes soluble proteins, including inactive replication factors that are not associated with chromatin (27) . As expected, the percentage of nuclei with detectable, chromatin-bound PCNA was reduced by PSM-RB expression (Fig. 1E , mock-infected, upper and lower panels, compare +/-Dox). In contrast, cyclin E efficiently restored PCNA binding in the presence of active RB (Fig. 1E , cyclin E-infected, upper and lower panels, -Dox).
Therefore, although entry into S-phase was stimulated, PSM-RB-mediated inhibition of replication persisted in the face of cyclin E overproduction and tethered PCNA. These data indicate that RB must regulate DNA replication at a second execution point, independent of CDK2 activity and downstream of PCNA loading.
PSM-RB inhibits the expression and activity of dNTP metabolic enzymes:
To identify this point, microarray analyses were utilized and data mined for enzymes that affect post-PCNA DNA replication (e.g. strand elongation). (RNR-R2). DHFR and TS are involved in the production of thymidine (28, 29) , while RNR regulates the rate-limiting conversion of all ribonucleotides (NDPs) to deoxyribonucleotides (dNDPs) (30) (31) (32) (33) .
To determine whether these changes in mRNA levels led to significant changes in protein expression, relative enzyme levels in Rat-16 and A2-4 cells were determined by immunoblotting. For DHFR, we observed no change at the protein level coincident with cell cycle inhibition at 16 hours following removal of Dox from the medium ( To confirm that dephosphorylation of endogenous RB and related proteins could downregulate dNTP enzyme expression, we analyzed the effects of ectopic p16ink4a
expression. P16ink4a inhibits CDK activity to prevent the phosphorylation of RB, p107, and p130, an event required for cell cycle inhibition (34, 35) . After a 16-hour infection, the expression of p16ink4a in CV1 cells was readily detectable by immunoblotting ( Fig.   2D ) and cell cycle inhibition was observed (data not shown).
The expression of p16ink4a led to the dephosphorylation/activation of endogenous RB, as indicated by the accumulation of its hypophosphorylated form (Fig. 2D) . Importantly, the protein levels of identified RB-repressed targets, RNR-R2, TS, and DHFR were significantly reduced ( Fig. 2D ). These data indicate that the endogenous RB-family proteins target dNTP enzyme expression during cell cycle arrest.
If the diminution of TS and RNR proteins in A2-4 cells was responsible for the inefficient DNA replication in the presence of cyclin E, their levels should be unaffected by cyclin E. Indeed, analysis of RNR-R2 and TS revealed that protein expression remained attenuated by PSM-RB in the presence of ectopic cyclin E expression (Fig. 2E ).
Thus, cyclin E restores PCNA activity but fails to recover the expression of dNTP metabolic enzymes in the presence of active RB.
Loss of RB leads to deregulated dNTP enzyme expression and antimetabolite resistance:
To directly assess the action of endogenous RB on dNTP metabolic enzymes, murine embryonic fibroblasts (MEFs) of Rb
genotype were utilized (17) . The loss of functional RB in MEFs has been shown to result in the overexpression of specific RB/E2F-regulated genes (36) (37) (38) . As a positive control for deregulated expression, we analyzed the cyclin E protein levels in the MEFs (Fig. 3A , compare lanes 1 and 2) (37).
In contrast, the levels of CDK4 were not deregulated. Analysis of the DHFR and TS protein levels by immunoblotting revealed that they were significantly increased in Rb 
dNTP pool alterations during RB-mediated arrest:
The data presented suggest that RB may regulate dNTP pools through modulation of TS and RNR expression. To test this hypothesis directly, cellular dNTP pools were analyzed in the presence or absence of active RB (23) . The control cell line, Rat-16, did not significantly alter the absolute or relative levels of dNTP pools upon Dox removal ( Fig. 4A and B, Rat-16). In contrast, a substantial decline in absolute dNTP levels and a significant change in the relative pool composition were observed 16 hours after the removal of Dox in A2-4 cells ( Fig. 4A and B, A2-4). In extracts from these RB-arrested cells, dATP levels were reduced 77%, dTTP levels were reduced 62%, and dGTP levels were reduced by approximately 50%. In contrast, the levels of dCTP did not appreciably change upon PSM-RB expression (Fig. 4A ). This initial attenuation of dNTPs persisted throughout the RB-induced cell cycle arrest ( Fig. 4A and B, A2-4). Thus, changes in the expression of metabolic enzymes by PSM-RB correlated with the significant reduction in specific dNTP levels. 5A ). To assess the effect of antimetabolite treatment on the replication machinery, PCNA activity was examined. In the presence of MTX and CdA, PCNA was efficiently tethered (Fig. 5B , compare +/-Dox to MTX and CdA). These observations are analogous to those seen upon ectopic cyclin E expression in RB-arrested cells (Fig. 1E ).
As has been described, these antimetabolites ultimately exert their effect by limiting available DNA precursors. As shown in Fig. 5C , MTX, FdU, and 5-FU efficiently attenuated dTTP levels (88%, 86%, and 68% respectively) when compared to the untreated control. In comparison, CdA treatment only attenuated the levels of dATP (68%) (Fig. 5C ). Thus, changes in dNTP levels of this magnitude were sufficient to inhibit DNA replication (Fig. 5A) . Importantly, the effects of these antimetabolites on dNTP levels were comparable to those observed in response to PSM-RB expression ( The function of RB to negatively regulate cellular proliferation is attributed to its transcriptional repression of E2F target genes (3). These E2F targets encompass a wide variety of cell cycle regulatory and metabolic enzymes (6, 10, 11) . It has been viewed that the downregulation of cell cycle regulatory machinery is the primary means by which RB limits cell proliferation. Consistent with this, RB has been shown to inhibit the expression of cyclin E, cyclin A, or CDK2 to impede S-phase progression (8, 16, 21, 25, (41) (42) (43) . This has been demonstrated through the reduction in amount of target proteins and subsequent attenuation of CDK2-associated kinase activity. Since CDK2 activity is required for DNA synthesis, this represents a mechanism through which RB inhibits cell cycle progression (2,12,13,15). Consistent with this idea, ectopic expression of cyclins E or A can partially overcome the inhibition of DNA replication mediated by active RB alleles (16, 21, 25, 26) . However, replication is incomplete; cells accumulate with S-phase DNA content and punctate BrdU labeling is observed.
Investigation of DNA replication machinery under these conditions indicated that PCNA is still associated with chromatin. PCNA is a component of the processive DNA polymerase holoenzyme and is one of the last regulatory effectors of DNA replication (15, 16) . Thus, the sustained inhibition achieved by PSM-RB in the presence of cyclin E represents a very late step in DNA replication and suggests that a specific action of RB may be to act downstream of the replication machinery to inhibit DNA synthesis. One of the few previously identified mechanisms through which replication is inhibited with PCNA tethered to chromatin is through the depletion of dNTP pools through the use of HU (44) .
The relative levels of dNTPs and the regulation of their synthesis play a critical role in DNA replication (30, 32, 45) . As such, expression of dNTP synthetic enzymes is cell cycle-regulated, with enhanced expression in S-phase. Even subtle changes in the levels of dNTPs can have a dramatic effect on DNA replication (45) . For example, inhibition of RNR activity by 50% using CdA leads to marked inhibition of cell cycle progression (40) . Additionally, dNTP levels vary within S-phase of the cell cycle Consistent with the idea that the attenuation of dNTP metabolism could be a mechanism through which RB inhibits DNA replication, E2F can modify the transcription of several metabolic enzymes (10, 11, 48, 49) . Specifically, it has been demonstrated that ectopic expression of E2F can stimulate the expression of DHFR, RNR-R1, RNR-R2, TS, and thymidine kinase (TK) in quiescent cells (10) . In fact, recent chromatin immunoprecipitation analyses have detected RB on the DHFR promoter at the G1/S transition (50) . Thus, E2F activity is believed to maintain the relative levels of enzyme mRNA during cell cycle progression. Here, we evaluated whether RB could specifically attenuate the expression of metabolic targets as part of a program to inhibit DNA replication. We find that RB reduces the mRNA levels of dNTP synthetic enzymes, with RNR-R2 being the most strongly repressed and DHFR being weakly repressed. We show that active RB targets the protein levels of RNR-R1, RNR-R2, DHFR and TS to effectively limit their abundance. As may be expected for metabolic enzymes, the kinetics of DHFR attenuation were slow and did not correlate with cell cycle inhibition achieved by active RB. However, the RNR-R2, RNR-R1 and TS enzymes were significantly attenuated, concurrent with cell cycle inhibition. In addition, activation of endogenous pocket proteins by ectopic p16ink4a expression led to the loss of RNR-R2, TS, and DHFR. Thus, the depletion of metabolic enzymes mediated by active RB could participate in the inhibition of DNA replication by virtue of altered dNTP pools.
In keeping with the significant role of dNTP metabolism in replication control, a number of therapeutic drugs are utilized that target dNTP synthetic enzymes (28, 29, 39) .
These antimetabolites generally function as pseudo-substrates that poison their specific target enzymes, leading to the depletion of dNTPs and subsequent inhibition of DNA replication. One mechanism through which resistance to antimetabolites is achieved is through overexpression of the target enzymes. We found that Rb Lastly, to directly assess the effect of RB on replication precursors, we analyzed dNTP pools. Surprisingly, no prior study has implicated a mammalian signal transduction cascade involved in cell cycle control to the level of dNTP and inhibition of DNA replication. In S. cerevisiae, several studies have demonstrated the involvement of SML1, an inhibitor of RNR, in the replicative response to DNA damage (52, 53) . As would be expected from the dramatic effects on protein expression, we find that dNTP pools are significantly reduced through the action of RB. The changes mediated by RB are comparable in magnitude to the changes elicited by antimetabolites that inhibit key enzymes involved in dNTP metabolism. Importantly, the inhibition of replication observed by the use of these antimetabolites was accompanied by the retention of PCNA on chromatin. Thus, cells arrested by antimetabolites behave in a manner analogous to those inhibited for DNA replication with both PSM-RB and cyclin E.
In summary, our findings reveal dual roles for RB in DNA replication control:
concurrent regulation of CDK2 activity and metabolic enzyme activity through transcriptional regulation. 
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